 | By LineusMedical Lineus Medical is pleased to announce a new distribution agreement with Venture Medical, a 100% New Zealand–owned medical supplier based in Auckland.
|
 | By Lineus Medical Lineus Medical has been granted five additional international patents for its flagship product, SafeBreak® Vascular, in Korea, Brazil, Australia, India, and China.
|
 | By Lineus Medical Lineus Medical is pleased to announce the appointment of Matt Stuckert to its Board of Directors. Stuckert was previously a member of the Lineus Technical Advisory Board.
|
| By Lineus Medical Lineus Medical announces the completion of a $4.579 million Series C funding round. The Series C round allowed Lineus Medical to expand its sales and clinical education team, secure international regulatory clearances, and obtain additional U.S.
|
 | By Lineus Medical Lineus Medical announces a significant reduction in price of nearly 15% for its flagship product, SafeBreak Vascular, in the United States.
|
 | By Lineus Medical Vance Clement, CEO of Lineus Medical, has been selected to join the Association of Vascular Access (AVA) Board of Directors as a Director at Large for a two-year term.
|
By Lineus Medical Lineus Medical has been awarded the 2023-2024 University of Arkansas College of Engineering Small Employer of the Year.
|
 | By Lineus Medical Lineus Medical is proud to announce the signing of a distribution agreement with the largest independent distributor of vascular access products in Canada, Canadian Hospital Specialties (CHS).
|
